LasoLab oversees fully vertical operations in the CBD Health and Wellness with seed-to-shelf cultivation, processing, international distribution and fulfillment assets spanning North America, serving the world.
The Laso process for evaluating partner acquisitions looks to immediate term profitability and net asset value, as well as positioning for leadership in the evolution of the CBD Wellness ecosystem.
LasoLab’s business extends to identified fully vertical operations in the
CBD Health and Wellness space with international reach.
Through this integrated model, along with its strategic Clinical Research relationships in the United Kingdom and EU, LasoLab’s objective is to deliver the highest quality of CBD and Wellness products in B2B transactions and end consumers transaction, while maximizing profits at every point of the supply chain.
CBD is a non-psychoactive cannabinoid offering Wellness effects for many medical indications including pain, anxiety and epilepsy. As such, significant opportunities exist for mass commercialization of CBD products. A wide range of potential applications (from nutritional supplements to pet food) will propel hemp-derived CBD products into mass market retailers in the coming years.